8400 The Health Network
Dan Goldstaub is an accomplished professional with extensive experience in clinical research and biotechnology. Currently serving as Co-Founder of PhaseV since January 2023, Goldstaub is focused on leveraging AI for clinical trials. As a member of 8400 The Health Network and an entrepreneur at Arkin Holdings, Goldstaub contributes to various health initiatives. Board memberships at Cytora Stem and QRGenetics, along with a speaker role at the Israeli Society for HealthTech, highlight involvement in the healthcare innovation community. Previously, Goldstaub held key leadership positions at MSD, including Executive Director of Clinical Research, overseeing clinical teams across multiple countries. With a strong academic foundation, including a PhD from the Weizmann Institute of Science, Goldstaub combines scientific knowledge with strategic leadership in the healthcare sector.
This person is not in any teams
8400 The Health Network
On a mission to drive an Israeli economic growth engine in HealthTech and accelerate global cure, 8400 The Health Network is weaving a network of HealthTech ecosystem leaders, across silos and sectors, who learn together and create gap-closing projects that will propel a thriving HealthTech industry in Israel. The 8400 Fellowship runs annual cohorts of 60 senior Israeli leaders each, for an intensive 17 day program across 7 months. The program’s tailor-made curriculum is creating a continuous platform for breaking silos, peer learning and designing ecosystem growth initiatives. 8400 fellowship graduates join the 8400 Network.